AMPLIA THERAPEUTICS LIMITED (ATX)

---

AI Coverage Rating: Active

ASX AI Signals has generated 3 signal for ATX during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest ATX Signals
02/06/2026	SELL
21/05/2026	SELL
15/05/2026	BUY
ATX Share Price
Current Price	$0.150
52 Week High	$0.355
52 Week Low:	$0.105
Trading at (% of 52 Week High)	42.25%

Business Overview

Amplia Therapeutics Limited (ASX: ATX) is a clinical-stage biopharmaceutical company focused on developing novel therapies for cancer and other serious diseases. The company specializes in precision oncology, aiming to create targeted treatments that address specific genetic mutations in tumors.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for AMPLIA THERAPEUTICS LIMITED (ATX) is supported by weak price performance and potential sector volatility. However, limited liquidity and market capitalization introduce some uncertainty, moderating the confidence level.

Latest  AMPLIA THERAPEUTICS LIMITED(ATX)   News